Phase 3 Multicenter Randomized Double-blind Trial of Brexpiprazole

Recruiting

18 years - 65 years

All

Phase 3

8 participants needed

1 Location

Brief description of study

Patients with post-traumatic stress disorder (PTSD) will be invited to participate in this research study.

Participants will be assigned to take one of the following: brexpiprazole, sertraline (also known as “Zoloft”; a marketed antidepressant that has been approved by the United States FDA for the treatment of PTSD), placebo (a pill without active study drug), or a combination of these. This is a blinded study, meaning neither the patient nor the doctor will know what you get.

If participant consents, they will be asked to complete the following research procedures: signing the informed consent form, evaluation to see if you qualify for the study. Vitals, EKG and labs will be done at certain time points. There will be rating scales (questions from study staff and outside raters) and some self-assessment questionnaires.

Participation will last approximately 17 weeks. Participants may receive up to $750.00 to complete the study.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: PTSD,post traumatic stress disorder
Age: 18 years - 65 years
Gender: All

Updated on 04 Aug 2024. Study ID: 850136

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Phase 3 Multicenter Randomized Double-blind Trial of Brexpiprazole as Combination Therapy with Sertraline in the Treatment of Adults with Post-traumatic Stress Disorder

Brief description of study

Eligibility of study

Find a site

Interested in the study